bioAffinity Technologies, Inc.日前宣布完成约180万美元的注册直接融资,本次融资通过发行普通股实现,股票定价按照纳斯达克市场规则执行。
此次融资采用按市价定价的方式进行,严格遵循纳斯达克交易所的相关规定和要求。
bioAffinity Technologies, Inc.日前宣布完成约180万美元的注册直接融资,本次融资通过发行普通股实现,股票定价按照纳斯达克市场规则执行。
此次融资采用按市价定价的方式进行,严格遵循纳斯达克交易所的相关规定和要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.